19 Nov AMR Action Fund

Despite the huge societal costs of #AMR, there is no viable market for new #antibiotics and little funding available to support clinical research. This year, the biopharmaceutical industry announced the launch of @AMRActionFund to respond to this challenge: https://bit.ly/3ovN1Xn

#WAAW2020